fakes Solovyov and Myasnikov about coronavirus

Obviously, the number of deaths is growing more slowly than the number of infections, and the number of hospitalized patients is even slower; however, the latter may be due to the limited capacity of the health care system. But it does not at all follow from this that the harsh measures taken by the Western countries are unjustified; a 9-fold increase in mortality is certainly a cause for alarm.

The illusion that the new strain causes a milder course of the disease may be due to the fact that France has a high vaccination rate: as of January 12, 74.9% of the population were fully vaccinated, and 40.8% received a booster dose. It is known that existing vaccines do not protect well from infection with “omicron”, but those vaccinated, as a rule, tolerate the disease easily.

Another strange statement was made in the dialogue between Myasnikov and Solovyov regarding the effect of vaccines:

Myasnikov:

– It turns out that: revaccination forever, do we get vaccinated every three months? The whole world comes to the fact that every three months to be vaccinated.

Solovyov:

– No, not the whole world comes to this, but those that your favorite mRNA vaccines use. Here Gunzburg just explained that your vectors are not needed every three months, but your mRNAs that were allowed in are necessary. And they need to be redone all the time.

In fact, mid-December Bloomberg reported on the results of a study conducted by the University of Washington and the Swiss pharmaceutical company Humabs Biomed SA: vector vaccines (Sputnik V, Johnson & Johnson, Sinopharm) showed an extremely low level of protection against omicron infection, and in the case of Sputnik this level turned out to be zero at all (which, however, does not apply to the effectiveness of protection against a severe course of the disease).

The manufacturer of one of the two mRNA vaccines, Pfizer, shortly after the introduction of the new strain, announced the start of work on the creation of a new version of its drug specifically designed for Omicron. January 10, head of the company Albert Burla declaredthat the production of a new version of the vaccine has already begun and will be available in March. It is believed that one of the advantages of mRNA vaccines (there are two now: Pfizer-BioNTech and Moderna) lies precisely in the fact that they are easy to adapt to new variants of the virus (according to Solovyov, “redo all the time”).

However, molecular biologist Konstantin Severinov doubts the need for such modifications. At the end of November last year, in an interview The Insider he noted:

“In itself, modifying next-generation vaccines, that is, vector vaccines like AstraZeneca or Sputnik V, or RNA vaccines like Moderna and Pfizer, is a piece of cake. Doesn’t take much time. But it is not at all obvious that this should be done. For example, no one made new vaccines for the delta. Another question is that changes in vaccines will then require the creation of an evidence base, clinical trials that would demonstrate that the new product actually has improved properties in relation to the new version of the virus. At present, there is no need for this. And despite the large number of mutations, there is no doubt that there will be an immune response to the new strain.”

As for revaccination every three months, this idea belongs personally to Myasnikov. This is probably how he understood the message that in the UK at the end of 2021 the Joint Committee on Vaccination and Immunization accepted solution: a booster dose of the vaccine can be administered not after 6 months, as previously recommended, but after 3 months. There is no question that after the booster dose some additional vaccination will be required.